Ernawaty Ernawaty

Dr. Ernawaty Ernawaty


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
Hario MegatsariHario Megatsari
Hario Megatsari
DKDian Kusuma
Dian Kusuma
EEErnawaty Ernawaty
Ernawaty Ernawaty
NPNuzulul K. Putri
Nuzulul K. Putri
Background: Previous studies have provided evidence of inequalities in the coverage of COVID-19 vaccination. However, evidence of such inequalities in delays in vaccinations is lacking. Our study examined the socioeconomic and geographic disparities in terms of days to get the first and second dose of COVID-19 vaccinations in Indonesia. Methods: We conducted a cross-sectional study using the WhatsApp messaging app and social media platforms during December 2021–February 2022. We distributed the questionnaire through our university network to reach all regions. We included 3592 adults aged 15+ years in our analysis. We used two main dependent variables: days to receive the first dose (after national vaccine rollout) and days to receive the second dose (after receiving the first dose). We examined a range of socioeconomic and geographic indicators, including education level, income level, formal employment, working in health facilities, being a health worker, and region. We controlled for sex, age, religion, and urbanicity. We performed multivariate logistic regressions in STATA 15. Results: Our findings show considerable delays in getting the first dose among participants (160.7 days or about 5.4 months on average) from Indonesia’s national COVID-19 vaccination rollout on 13 January 2021. However, we found a shorter period to receive the second dose after receiving the first dose (41.1 days on average). Moreover, we found significant socioeconomic (i.e., education, income, formal employment, working in health facilities, and being a health worker) and geographic (i.e., in and out of the Java region) inequalities in terms of delays in getting the first dose. However, we did not find significant inequalities in getting the second dose for most inequality indicators, except for working in health facilities. By region, we found that participants living in more deprived areas (out of the Java region) received the second dose 4.9 days earlier. One of the study’s key limitations is that there may be an inherent bias with respect to socioeconomics factors since it was conducted online (web-based). Conclusions: While there were considerable delays in getting the first dose, especially among those of a lower socioeconomic status and those in more deprived areas, the waiting time for the second dose was relatively similar for everyone once they were in the system. Effective efforts to address inequalities are essential to ensuring the effectiveness of the national COVID-19 vaccination rollout.

Thinni RochmahThinni Rochmah
Thinni Rochmah
AWAnggun Wulandari
Anggun Wulandari
MDMaznah Dahlui
Maznah Dahlui
EEErnawaty Ernawaty
Ernawaty Ernawaty
RWRatna Dwi Wulandari
Ratna Dwi Wulandari
Cataracts are the second most prioritized eye disease in the world. Cataracts are an expensive treatment because surgery is the only method that can treat the disease. This study aims to analyze the cost effectiveness of each operating procedure. Specifically, phacoemulsification and Small Incision Cataract Surgery (SICS) with Disability-Adjusted Life Years (DALYs) as the effectiveness indicator is used. This study is an observational analytic study with a prospective framework. The sample size is 130 patients who have undergone phacoemulsification and 25 patients who have undergone SICS. The DALY for phacoemulsification at Day-7 (D-7) is 0.3204, and at Day-21 (D-21), it is 0.3204, while the DALY for SICS at D-7 is 0.3060, and at D-21, it is 0.3158. The incremental cost effectiveness ratio (ICER) for cataract surgery at D-7 is USD $1872.49, and at D-21, it is USD $5861.71, whereas the Indonesian Gross Domestic Product (GDP) is USD $4174.90. In conclusion, the phacoemulsification technique is more cost effective than the SICS technique. The ICER value is very cost effective at D-7 post-surgery compared to at D-21 post-surgery because the ICER is less than 1 GDP per capita per DALY.

22 March 2020 in Vaccines
Verified
Journal Article
Open access
PDF file
YCYu-Chia Chang
Yu-Chia Chang
YHYu-Tung HUANG
Yu-Tung HUANG
LCLong-Sheng Chen
Long-Sheng Chen
HTHo-Jui Tung
Ho-Jui Tung
KHKuang-Hua Huang
Kuang-Hua Huang
Szu-Yuan WuSzu-Yuan Wu
Szu-Yuan Wu
This is the first and largest population-based cohort study to demonstrate that influenza vaccination reduced all-cause mortality and influenza-related hospitalization in elderly individuals with a disability. Purpose: To estimate the protective effect of influenza vaccination in elderly individuals with a disability by conducting a propensity score-matched (PSM), nationwide, population-based cohort study. Methods: Data from Taiwan’s National Health Insurance Research Database were used in this study. Generalized estimating equations (GEEs) were used to compare outcomes between the vaccinated and unvaccinated cohorts. The GEE logit was used to estimate the relative risks of death and hospitalization after influenza vaccination. Adjusted odds ratios (aORs) were used to estimate relative risk. Results: The matching process yielded a final cohort of 272 896 elderly individuals with a disability (136 448 individuals in each cohort). In multivariate GEE analyses, aOR (vaccinated vs. unvaccinated) and 95% confidence interval (CI) of death were 0.70 (0.68–0.72). The aORs (95% CIs) of hospitalization for influenza and pneumonia, respiratory diseases, respiratory failure, heart disease, hemorrhagic stroke, and ischemic stroke were 0.98 (0.95–1.01), 0.96 (0.94–0.99), 0.85 (0.82–0.89), 0.96 (0.93–0.99), 0.85 (0.75–0.97), and 0.89 (0.84–0.95), respectively. The length of stay and medical expenditure exhibited greater reduction in vaccinated elderly individuals with a severe and very severe disability than in unvaccinated elderly individuals. Conclusions: Influenza vaccination reduced all-cause mortality, influenza-related hospitalization, length of stay, and medical expenditure in elderly individuals with a disability. The decrease in the length of stay and medical expenditure because of influenza vaccination was proportional to the severity of disability.

30 September 2021 in Media Kesehatan Masyarakat Indonesia
Verified
Journal Article
Open access
PDF file
EMErlian Indah Mustikawati
Erlian Indah Mustikawati
EEErnawaty Ernawaty
Ernawaty Ernawaty
Adolescents represent one of the vulnerable groups that could suffer from mental and psychosocial health during the COVID-19 pandemic. This study aims to analyze behavioral differences in adolescents who have experienced anxiety disorders during the COVID-19 pandemic. The study used a cross-sectional design on 122 adolescents in East Java during the pandemic. Data was collected through a questionnaire via Google Forms in May 2021. Data analysis in this study used the Mann–Whitney test on SPSS Statistics 26. The current study found that male respondents (80%) show a higher tendency to have anxiety disorders compared with female respondents (74%). Meanwhile, there was no difference in the help-seeking behavior based on the gender of adolescent respondents’ who experienced anxiety disorders during the COVID-19 pandemic (p=0.291). The current study also found that there is no difference in help-seeking behavior between adolescents who experience anxiety disorders or those who do not experience anxiety disorder (p=0.449). Most adolescents with anxiety disorders tend to discuss their issues with friends and family to relieve anxiety, whereas some do not seek help because they can cope with anxiety disorders on their own, they think they do not really need help, they feel that no one cares about their problems, and there is a lack of supporting health facilities in the youth environment. Teenagers in East Java are advised to consult their mental health problems with experts to find relevant solutions.

2 March 2020 in Vaccines
Verified
Journal Article
Open access
PDF file
YCYu-Chia Chang
Yu-Chia Chang
HTHo-Jui Tung
Ho-Jui Tung
YHYu-Tung HUANG
Yu-Tung HUANG
CLChin-Te Lu
Chin-Te Lu
EEErnawaty Ernawaty
Ernawaty Ernawaty
Szu-Yuan WuSzu-Yuan Wu
Szu-Yuan Wu
Purpose: The effects of influenza vaccines are unclear for elderly individuals with disabilities. We use a population-based cohort study to estimate the effects of influenza vaccines in elderly individuals with and without disabilities. Methods: Data were taken from the National Health Insurance Research Database and Disabled Population Profile of Taiwan. A total of 2,741,403 adults aged 65 or older were identified and 394,490 were people with a disability. These two groups were further divided into those who had or had not received an influenza vaccine. Generalized estimating equations (GEE) were used to compare the relative risks (RRs) of death and hospitalization across the four groups. Results: 30.78% elderly individuals without a disability and 34.59% elderly individuals with a disability had vaccinated for influenza. Compared to the unvaccinated elderly without a disability, the vaccinated elderly without a disability had significantly lower risks in all-cause mortality (RR = 0.64) and hospitalization for any of the influenza-related diseases (RR = 0.91). Both the unvaccinated and vaccinated elderly with a disability had significantly higher risks in all-cause mortality (RR = 1.81 and 1.18, respectively) and hospitalization for any of the influenza-related diseases (RR = 1.73 and 1.59, respectively). Conclusions: The elderly with a disability had higher risks in mortality and hospitalization than those without a disability; however, receiving influenza vaccinations could still generate more protection to the disabled elderly.

1 September 2022 in International Journal of Public Health Science (IJPHS)
Verified
Journal Article
Open access
PDF file
FSFebri Endra Budi Setyawan
Febri Endra Budi Setyawan
SSStefanus Supriyanto
Stefanus Supriyanto
EEErnawaty Ernawaty
Ernawaty Ernawaty
RLRetno Lestari
Retno Lestari
Patient satisfaction and loyalty are widely cited as markers of healthcare quality. Organizational commitment assists first-level health facilities in achieving the goals by incorporating physicians in the implementation of holistic and comprehensive care. This study aims to analyze a structural model of physician organizational commitment, patient satisfaction, and loyalty in first-level health facilities. This study used an explanatory research design with a total sample of 199 physicians and 980 patients in 30 public and private first-level health facilities within the collaboration of national healthcare and social security, chosen by systematic random sampling. Analysis was performed by using partial least squares–structural equation modeling (PLS-SEM). Physician factors, organizational factors, and non-organizational factors have the strongest influence on physician organizational commitment (80.2%). To sum up, major efforts should be made to improve organizational commitment among physicians in providing holistic and comprehensive care in first-level health facilities to boost patient satisfaction and loyalty.